The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized controlled phase II trial of simvastatin as prophylaxis against radiation-induced skin toxicity in breast cancer patients.
Shibu Joseph
No relevant relationships to disclose
Glenys Round
No relevant relationships to disclose
Michael B. Jameson
No relevant relationships to disclose
Jenny May Boyd
No relevant relationships to disclose
Rajan Ragupathy
No relevant relationships to disclose